Kennametal Foundation will help patients better navigate their cancer journey
October 14, 2010, Victoria, BC – The Kennametal Foundation announced a donation of $15,000 to the BC Cancer Foundation’s Inspire the World campaign. This …
Grace SplitMango
Research moving us closer to personalized medicine
Researchers with the BC Cancer Agency’s Genome Sciences Centre developed two new approaches – ALEXASeq and Trans-ABySS – to characterize how the information in …
League Assets Corp. donation will help families of cancer patients
October 6, 2010, Victoria, B.C. - BC Cancer Foundation is pleased to announce a donation of $50,000 from League Assets Corp. to its Inspire …
PET/CT Program Gets Major Boost With New Facility
September 27, 2010, Vancouver, BC – The official opening of a new $15-million radiopharmaceutical facility brings the production of radiotracers used in PET/CT scans …
BC researchers uncover new ovarian cancer gene — ARID1A
Researchers with the Ovarian Cancer Research (OvCaRe) program at the BC Cancer Agency and Vancouver Coastal Health Research Institute found a major new tumour-suppressing …
Ovarian cancer researchers request practice changes to protect against ovarian cancer
VANCOUVER, BC - Gynecologic oncologists with the Ovarian Cancer Research Program at Vancouver General Hospital (VGH) and the BC Cancer Agency have begun …
1,110 participants begin day two of $2.4 million, 60-km Weekend Walk BC Cancer Foundation’s 7th annual fundraiser a signature success
August 15, 2010, Vancouver, BC - The BC Cancer Foundation announced yesterday that 1,100 participants raised over $2.4 million in its seventh annual Shoppers …
Personalized genome sequencing in cancer treatment—a major breakthrough in care
August 9, 2010, Vancouver, BC – Researchers at the BC Cancer Agency Genome Sciences Centre have provided the first published example of genome-scale RNA …
Scientists discover cancer-causing gene — helping to distinguish lung cancer subtypes
Researchers identified a cancer-causing gene, BRF2, specific to squamous lung cell carcinoma, which could be a marker for this type of lung cancer and …
BC scientists develop new drug candidate for prostate cancer
June 15, 2010, Vancouver, B.C. – Scientists in B.C. have developed a unique experimental drug, EPI-001, that shrinks prostate cancer tumours in the lab. …